Skip to main content

Advertisement

Log in

The Epidemiology of Obesity and Gastrointestinal and Other Diseases: An Overview

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The worldwide prevalence of obesity continues to increase, with devastating implications for overall health. Epidemiological trends indicate the primary contributors are environmental (e.g., increased caloric intake, lack of exercise), although the evidence is surprisingly equivocal. Increased body mass index (BMI) is associated with an increase in all-cause mortality and in diseases related to this increasing mortality rate, such as diabetes mellitus, cardiovascular disease, and cancer, including those of the gastrointestinal system. Some of these associations are even more pronounced when obesity is measured by waist-to-hip ratio, a marker of visceral adipose tissue, versus BMI. Higher BMI is related to increased risk of developing gall stones, and obese patients experience GI symptoms, such as vomiting and diarrhea, more often compared with those of normal body mass. Although the exact cause remains uncertain, these symptoms may be connected to eating habits or to changes in gastrointestinal motility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Data from National Health and Nutrition Examination Survey. Centres for Disease Control and Prevention, National Center for Health Statistics, Health, United States 2006

  2. Wang Y, Mi J, Shan XY, Wang QJ, Ge KY (2007) Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes 31:177–188. doi:10.1038/sj.ijo.0803354

    Article  CAS  Google Scholar 

  3. World Health Organization. Available at: http://www.who.int/ncd_surveillance/infobase/web/InfoBaseCommon/Images/bmioverweightmaps.gif. Accessed May 31 2007

  4. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J et al (2005) A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 352:1138–1145. doi:10.1056/NEJMsr043743

    Article  PubMed  CAS  Google Scholar 

  5. Lyon HN, Hirschhorn JN (2005) Genetics of common forms of obesity: a brief overview. Am J Clin Nutr 82(Suppl 1):215S–217S

    PubMed  CAS  Google Scholar 

  6. Farooqi IS, Wangensteen T, Collins S, Kimber W, Matarese J, Keogh JM et al (2007) Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 356:237–247. doi:10.1056/NEJMoa063988

    Article  PubMed  CAS  Google Scholar 

  7. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak GJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295:1549–1555. doi:10.1001/jama.295.13.1549

    Article  PubMed  CAS  Google Scholar 

  8. Rodriguez Artalejo F, Lopez Garcia E, Gutierrez-Fisac JL, Banegas Banegas JR, Lafuente Urdinguio PJ, Dominguez Rojas V (2002) Changes in the prevalence of overweight and obesity and their risk factors in Spain, 1987–1997. Prev Med 34:72–81. doi:10.1006/pmed.2001.0962

    Article  PubMed  Google Scholar 

  9. Viner RM, Cole TJ (2006) Who changes body mass between adolescence and adulthood? Factors predicting change in BMI between 16 year and 30 years in the 1970 British Birth Cohort. Int J Obes 30:1368–1374. doi:10.1038/sj.ijo.0803183

    Article  CAS  Google Scholar 

  10. Ward H, Tarasuk V, Mendelson R (2007) Socioeconomic patterns of obesity in Canada: modeling the role of health behaviour. App Physiol Nutr Metab 2:206–216

    Article  Google Scholar 

  11. Vieweg VR, Johnston CH, Lanier JO, Fernandez A, Pandurangi AK (2007) Correlation between high risk obesity groups and low socioeconomic status in school children. South Med J 100:8–13

    PubMed  Google Scholar 

  12. Fernald LC (2007) Socio-economic status and body mass index in low-income Mexican adults. Soc Sci Med 64:2030–2042. doi:10.1016/j.socscimed.2007.02.002

    Article  PubMed  Google Scholar 

  13. Vanasse A, Demers M, Hemiari A, Courteau J (2006) Obesity in Canada: where and how many? Int J Obes 30:677–683. doi:10.1038/sj.ijo.0803168

    Article  CAS  Google Scholar 

  14. Janssen I, Boyce WF, Simpson K, Pickett W (2006) Influence of individual- and area-level measures of socioeconomic status on obesity, unhealthy eating, and physical inactivity in Canadian adolescents. Am J Clin Nutr 83:139–145

    PubMed  CAS  Google Scholar 

  15. Prentice AM, Jebb SA (1995) Obesity in Britain: gluttony or sloth? BMJ 311:437–439

    PubMed  CAS  Google Scholar 

  16. Kaplan MS, Huguet N, Newsom JT, McFarland BH, Lindsay J (2003) Prevalence and correlates of overweight and obesity among older adults: findings from the Canadian national population health survey. J Gerontol A Biol Sci Med Sci 58:1018–1030

    PubMed  Google Scholar 

  17. Harrison M, Burns CF, McGuinness M, Heslin J, Murphy NM (2006) Influence of a health education intervention on physical activity and screen time in primary school children: ‘switch off—get active’. J Sci Med Sport 9:388–394. doi:10.1016/j.jsams.2006.06.012

    Article  PubMed  Google Scholar 

  18. Kant AK, Graubard BI (2006) Secular trends in patterns of self-reported food consumption of adult Americans: NHANES 1971–1975 to NHANES 1999–2002. Am J Clin Nutr 84:1215–1223

    PubMed  CAS  Google Scholar 

  19. Field AE, Austin SB, Gillman MW, Rosner B, Rockett HR, Colditz GA (2004) Snack food intake does not predict weight change among children and adolescents. Int J Obes Relat Metab Disord 28:1210–1216. doi:10.1038/sj.ijo.0802762

    Article  PubMed  CAS  Google Scholar 

  20. Heini AF, Weinsier RL (1997) Divergent trends in obesity and fat intake patterns: the American paradox. Am J Med 102:259–264. doi:10.1016/S0002-9343(96)00456-1

    Article  PubMed  CAS  Google Scholar 

  21. Keith SW, Redden DT, Katzmarzyk PT, Boggiano MM, Hanlon EC, Benca RM et al (2006) Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes 30:1585–1594. doi:10.1038/sj.ijo.0803326

    Article  CAS  Google Scholar 

  22. Hill JO, Wyatt HR, Reed GW, Peters JC (2003) Obesity and the environment: where do we go from here? Science 299:853–855. doi:10.1126/science.1079857

    Article  PubMed  CAS  Google Scholar 

  23. Christakis NA, Fowler JH (2007) The spread of obesity in a large social network over 32 years. N Engl J Med 357:370–379. doi:10.1056/NEJMsa066082

    Article  PubMed  CAS  Google Scholar 

  24. Egger G, Swinburn B (1997) An “ecological” approach to the obesity pandemic. BMJ 315:477–480

    PubMed  CAS  Google Scholar 

  25. Ogilvie D, Hamlet N (2005) Obesity: the elephant in the corner. BMJ 331:1545–1548. doi:10.1136/bmj.331.7531.1545

    Article  PubMed  Google Scholar 

  26. Ellaway A, Macintyre S, Bonnefoy X (2005) Graffiti, greenery, and obesity in adults: secondary analysis of European cross sectional survey. BMJ 331:611–612. doi:10.1136/bmj.38575.664549.F7

    Article  PubMed  Google Scholar 

  27. Bender R, Jockel KH, Trautner C, Spraul M, Berger M (1999) Effect of age on excess mortality in obesity. JAMA 281:1498–1504. doi:10.1001/jama.281.16.1498

    Article  PubMed  CAS  Google Scholar 

  28. Flegal KM, Graubard BI, Williamson DF, Gail MH (2005) Excess deaths associated with underweight, overweight, and obesity. JAMA 293:1861–1867. doi:10.1001/jama.293.15.1861

    Article  PubMed  CAS  Google Scholar 

  29. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB (2003) Years of life lost due to obesity. JAMA 289:187–193. doi:10.1001/jama.289.2.187

    Article  PubMed  Google Scholar 

  30. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM (2007) The epidemiology of obesity. Gastroenterology 132:2087–2102. doi:10.1053/j.gastro.2007.03.052

    Article  PubMed  Google Scholar 

  31. Park JH, Yoon SJ, Lee H, Jo HS, Lee SI, Kim Y et al (2006) Burden of disease attributable to obesity and overweight in Korea. Int J Obes 30:1661–1669. doi:10.1038/sj.ijo.0803321

    Article  Google Scholar 

  32. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R et al (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355:763–778. doi:10.1056/NEJMoa055643

    Article  PubMed  CAS  Google Scholar 

  33. McGee DL (2005) Diverse populations collaboration. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 15:87–97. doi:10.1016/j.annepidem.2004.05.012

    Article  PubMed  Google Scholar 

  34. Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E et al (2006) Body-mass index and mortality in Korean men and women. N Engl J Med 355:779–787. doi:10.1056/NEJMoa054017

    Article  PubMed  CAS  Google Scholar 

  35. Gu D, He J, Duan X, Reynolds K, Wu X, Chen J et al (2006) Body weight and mortality among men and women in China. JAMA 295:776–783. doi:10.1001/jama.295.7.776

    Article  PubMed  CAS  Google Scholar 

  36. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr (1999) Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341:1097–1105. doi:10.1056/NEJM199910073411501

    Article  PubMed  CAS  Google Scholar 

  37. Must A, Spadano J, Coakley EH, Field AE, Colditz GA, Dietz WH (1999) The disease burden associated with overweight and obesity. JAMA 282:1523–1529. doi:10.1001/jama.282.16.1523

    Article  PubMed  CAS  Google Scholar 

  38. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH et al (2001) Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161:1581–1586. doi:10.1001/archinte.161.13.1581

    Article  PubMed  CAS  Google Scholar 

  39. Cooper C, Inskip H, Croft P, Campbell L, Smith G, McLaren M et al (1998) Individual risk factors for hip osteoarthritis: obesity, hip injury, and physical activity. Am J Epidemiol 147:516–522

    PubMed  CAS  Google Scholar 

  40. Bray GA (1996) Health hazards of obesity. Endocrinol Metab Clin North Am 25:907–919. doi:10.1016/S0889-8529(05)70361-3

    Article  PubMed  CAS  Google Scholar 

  41. Yan LL, Daviglus ML, Liu K, Stamler J, Wang R, Pirzada A et al (2006) Midlife body mass index and hospitalization and mortality in older age. JAMA 295:190–198. doi:10.1001/jama.295.2.190

    Article  PubMed  CAS  Google Scholar 

  42. McMillan DC, Sattar N, Lean M, McArdle CS (2006) ABC of obesity: obesity and cancer. BMJ 333:1109–1111. doi:10.1136/bmj.39042.565035.BE1

    Article  PubMed  Google Scholar 

  43. Bergström A, Pisani P, Tenet V, Wolk A, Adami HO (2001) Overweight as an avoidable cause of cancer in Europe. Int J Cancer 91:421–30. doi :10.1002/1097-0215(200002)9999:9999<::AID-IJC1053>3.0.CO;2-T

  44. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638. doi:10.1056/NEJMoa021423

    Article  PubMed  Google Scholar 

  45. Kolovou GD, Anagnostopoulou KK, Salpea KD, Mikhailidis DP (2007) The prevalence of metabolic syndrome in various populations. Am J Med Sci 333:362–371. doi:10.1097/MAJ.0b013e318065c3a1

    Article  PubMed  Google Scholar 

  46. Giovannucci E (2003) Nutrition, insulin, insulin like growth factors and cancer. Horm Metab Res 35:694–704. doi:10.1055/s-2004-814147

    Article  PubMed  CAS  Google Scholar 

  47. Stürmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ (2006) Metabolic abnormalities and risk for colorectal cancer in the physicians’ health study. Cancer Epidemiol Biomarkers Prev 15:2391–2397. doi:10.1158/1055-9965.EPI-06-0391

    Article  PubMed  Google Scholar 

  48. Wei EK, Ma J, Pollak MN, Rifai N, Fuch CS, Hankinson SE et al (2006) C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women. Cancer Epidemiol Biomarkers Prev 15:750–755. doi:10.1158/1055-9965.EPI-05-0820

    Article  PubMed  CAS  Google Scholar 

  49. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911–919. doi:10.1016/j.jaci.2005.02.023

    Article  PubMed  CAS  Google Scholar 

  50. Wei EK, Giovannucci E, Fuchs CS, Willet WC, Mantzoros CS (2005) Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 97:1688–1694

    Article  PubMed  CAS  Google Scholar 

  51. Kelesidis I, Kelesidis T, Mantzoros CS (2006) Adiponectin and cancer: a systematic review. Br J Cancer 94:1221–1225. doi:10.1038/sj.bjc.6603051

    Article  PubMed  CAS  Google Scholar 

  52. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P et al (2005) INTERHEART study investigators. Obesity and the risk of myocardial infarction in 27, 000 participants from 52 countries: a case-control study. Lancet 366:1640–1649. doi:10.1016/S0140-6736(05)67663-5

    Article  PubMed  Google Scholar 

  53. Giovannucci E, Michaud D (2007) The role of obesity and related metabolic disturbances in cancers of the colon, prostate and pancreas. Gastroenterology 132:2208–2225. doi:10.1053/j.gastro.2007.03.050

    Article  PubMed  CAS  Google Scholar 

  54. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW et al (2004) Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350:2549–2557. doi:10.1056/NEJMoa033179

    Article  PubMed  CAS  Google Scholar 

  55. Thörne A, Lönnqvist F, Apelman J, Hellers G, Arner P (2002) A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord 26:193–199. doi:10.1038/sj.ijo.0801871

    Article  PubMed  Google Scholar 

  56. Folsom AR, Kushi LH, Anderson KE, Mink PJ, Olson JE, Hong CP et al (2000) Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa women’s health study. Arch Intern Med 160:2117–2128. doi:10.1001/archinte.160.14.2117

    Article  PubMed  CAS  Google Scholar 

  57. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL (2006) Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut 55:708–714. doi:10.1136/gut.2005.076133

    Article  PubMed  Google Scholar 

  58. Syngal S, Coakley EH, Willett WC, Byers T, Williamson DF, Colditz GA (1999) Long-term weight patterns and risk for cholecystectomy in women. Ann Intern Med 130:471–477

    PubMed  CAS  Google Scholar 

  59. Martinez J, Johnson CD, Sanchez-Paya J, de Madaria E, Robles-Diaz G, Pérez-Mateo M (2006) Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology 6:206–209. doi:10.1159/000092104

    Article  PubMed  CAS  Google Scholar 

  60. Johnson CD, Toh SK, Campbell MJ (2004) Combination of APACHE-II score and an obesity score (APACHE-O) for the prediction of severe acute pancreatitis. Pancreatology 4:1–6. doi:10.1159/000077021

    Article  PubMed  CAS  Google Scholar 

  61. Delgado-Aros S, Locke GR 3rd, Camilleri M, Talley NJ, Fett S, Zinsmeister AR et al (2004) Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol 99:1801–1806. doi:10.1111/j.1572-0241.2004.30887.x

    Article  PubMed  Google Scholar 

  62. Talley NJ, Howell S, Poulton R (2004) Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am J Gastroenterol 99:1807–1814. doi:10.1111/j.1572-0241.2004.30388.x

    Article  PubMed  Google Scholar 

  63. Levy RL, Linde JA, Feld KA, Crowell MD, Jeffery RW (2005) The association of gastrointestinal symptoms with weight, diet, and exercise in weight-loss program participants. Clin Gastroenterol Hepatol 3:992–996. doi:10.1016/S1542-3565(05)00696-8

    Article  PubMed  Google Scholar 

  64. Talley NJ, Quan C, Jones MP, Horowitz M (2004) Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil 16:413–419. doi:10.1111/j.1365-2982.2004.00530.x

    Article  PubMed  CAS  Google Scholar 

  65. Shinomiya T, Fukunaga M, Akamizu T, Irako T, Yokode M, Kangawa K et al (2005) Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients. Scand J Gastroenterol 40:648–653. doi:10.1080/00365520510015403

    Article  PubMed  CAS  Google Scholar 

  66. Bercik P, Verdu EF, Collins SM (2005) Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am 34:235–245. doi:10.1016/j.gtc.2005.02.007

    Article  PubMed  Google Scholar 

  67. John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA (2006) Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther 23:1511–1523. doi:10.1111/j.1365-2036.2006.02915.x

    Article  PubMed  CAS  Google Scholar 

  68. Ma L, Tataranni PA, Hanson RL, Infante AM, Kobes S, Bogardus C et al (2005) Variations in peptide YY and Y2 receptor genes are associated with severe obesity in Pima Indian men. Diabetes 54:1598–1602. doi:10.2337/diabetes.54.5.1598

    Article  PubMed  CAS  Google Scholar 

  69. Wolford JK, Colligan PB, Gruber JD, Bogardus C (2003) Variants in the interleukin 6 receptor gene are associated with obesity in Pima Indians. Mol Genet Metab 80:338–343. doi:10.1016/j.ymgme.2003.07.003

    Article  PubMed  CAS  Google Scholar 

  70. Schulz LO, Bennett PH, Ravussin E, Kidd JR, Kidd KK, Esparza J et al (2006) Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S. Diabetes Care 29:1866–1871. doi:10.2337/dc06-0138

    Article  PubMed  Google Scholar 

  71. Hill JO, Peters JC, Wyatt HR (2007) The role of public policy in treating the epidemic of global obesity. Clin Pharmacol Ther 81:772–775. doi:10.1038/sj.clpt.6100107

    Article  PubMed  CAS  Google Scholar 

  72. Avenell A, Broom J, Brown TJ, Roobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM (2004) Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 8(21):iii-iv, 1–182

Download references

Acknowledgments

Dr. Moayyedi has acted as an independent medical consultant for AstraZeneca and Janssen Ortho. He is on the speakers' bureau for AstraZeneca, Janssen Ortho, Nycomed, and Eisai. He holds a chair that is funded partly through an unrestricted donation from AstraZeneca Canada to McMaster University. The scientific roundtable was funded by Eisai, Inc. and PriCara, a Unit of Ortho-McNeil, Inc. International Meetings and Science, Inc. organized the roundtable and provided editorial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul Moayyedi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moayyedi, P. The Epidemiology of Obesity and Gastrointestinal and Other Diseases: An Overview. Dig Dis Sci 53, 2293–2299 (2008). https://doi.org/10.1007/s10620-008-0410-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0410-z

Keywords

Navigation